Skip to main content

2018 Research Year in Review and Look Ahead

November 15, 2018

In this webinar, our expert panelists discuss progress this year in developing new treatments and tests for Parkinson's and look ahead to 2019.

Webinar Details


Thursday, November 15, 2018


1 hr


12:00 pm ET

  • MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

    Date of Original Release: November 15, 2018
    Date Credit Expires: November 15, 2020

    Learning Objectives
    • Discuss new therapies to manage Parkinson’s symptoms.
    • Summarize what therapies are in clinical trials to slow or stop Parkinson’s progression.
    • Describe progress toward tests to diagnose and track Parkinson’s.
    • Explain anticipated progress in the Parkinson’s field in 2019.  
    Target Audience

    This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.


    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Oakstone Publishing, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


    Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.


    Soania Mathur, MD (Moderator)
    Retired family physician
    Co-Chair, MJFF Patient Council
    Nothing to disclose

    Andrew Siderowf, MD
    Director, Parkinson's Disease and Movement Disorders Center
    Chief, Movement Disorders Division, 
    University of Pennsylvania
    Co-Principal Investigator, Parkinson’s Progression Markers Initiative
    Advisory Roles: Biogen, Merck, Voyager, Wave, Prilenia

    Todd Sherer, PhD
    The Michael J. Fox Foundation
    Wife works at Pfizer.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.